News

The new results showed that MDV3100 continues to show durable antitumor activity as evaluated by median times to prostate-specific antigen (PSA) progression and radiographic progression. These findings confirm

The acquisition enables Daiichi Sankyo to leverage existing resources to more cost-effectively supplement its operations rather than build a new facility. The facility is expected to be operational

The LifeNexus Personal Health Card stores comprehensive health information for individuals and their family members on its iChip (the Individually Controlled Health Information Platform) which is encrypted and

Genus Oncology has also filed an investigational new drug (IND) application with the US Food & Drug Administration (FDA). The prospective, open-label Phase I trial is designed to

Veeva Vault will deliver on the promise of deploying a flexible content management system across the entire company, spanning promotional materials management, R&D submissions, quality and manufacturing, and

The NG Class represents a new detergent family based on the maltose-neopentyl amphiphile design, and is more capable than current leading detergents, such as n-dodecyl-ß-D-maltoside (DDM) in speeding

In addition, Panmure Gordon has conditionally placed £3.4 million of existing shares on behalf of certain selling shareholders. e-Therapeutics is developing its own drug development pipeline, which includes

Fosmidomycin is a molecule that possesses antimalarial and antibacterial activity. The co-development project follows reports of the emergence of artemisinin resistance on the Thai-Cambodian border. Jomaa Pharma MD

Thestherapeutics include RNAi-, microRNA- and antisense-based drugs. Marina Biotech recently entered into a partnership with Debiopharm to fully fund the development of its bladder cancer program using its